Sep 30

QP 36 - From Brachy to Beams to Biologics: Innovations in Esophageal and Liver Cancer

1213 - Long-Term Survival and Biomarker-Based Exploratory Analysis of Nimotuzumab Combined with SIB-IMRT in Locally Advanced Esophageal Cancer: Insights from a Phase II Clinical Trial

08:15am - 08:20am ET

Room 162

Presenter(s)

Lan Wang, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei